Categories

Meta

Recent Posts

Nanomedicine Center in favour of Nucleoprotein Machines receives $16.1 million NIH trophy

Posted in Medical Condition on October 29th, 2010

The Georgia Tech-led Nanomedicine Center representing Nucleoprotein Machines has received an accord of $16.1 million championing five years as district of its renewal close the Country-wide Institutes of Healthiness (NIH). The eight-institution enquire band plans to chase occurrence of a clinically sensible gene rectification technology throughout single-gene disorders and establish the technology’s efficacy with sickle chamber cancer.

Read the rest of this entry »

Momenta receives certificate of invention fitted methods to rank enoxaparin

Posted in Medical Patent on October 27th, 2010

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology business specializing in the characterization and engineering of complex drugs, announced today that the U.S. Unmistakeable and Trademark Bit has issued U.S. Charter No. 7,816,144, entitled "Evaluating Mixtures of Shaky Molecular Albatross Heparins By way of Confine Profiles or Gyve Mapping". The trade mark includes claims to methods of analyzing and processing enoxaparin Read the rest of this entry »

Rockwell receives U.S. control representing SFP formulation

Posted in Medical Patent on October 27th, 2010

Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical assembly oblation innovative products and services targeting end-stage renal plague (ESRD), lasting kidney murrain (CKD), and iron deficiency anemia, announced today that it has received recognize from the U.S. Unmistakable and Trademark Corporation representing tangible issuance on its proprietary GMP formulation benefit of Soluble Ferric Pyrophosphate (SFP), the Company’s Read the rest of this entry »

Celtic Pharma receives US trade name as a replacement for methods to consider knocker, colon cancer

Posted in Medical Patent on October 27th, 2010

Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma") today announced that the U.S. Plain Task has issued U.S. manifest 7,816,323, through despite creative methods to review core and colon cancers using a mixture remedial programme of Xerecept® with Avastin®.  The certificate of invention is based on in vivo text demonstrating the prosperous constraint of tumor nurturing using a mix remedial programme nearer. This letters patent Read the rest of this entry »

Momenta receives letters patent someone is concerned methods to gauge enoxaparin

Posted in Medical Patent on October 27th, 2010

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology firm specializing in the characterization and engineering of complex drugs, announced today that the U.S. Certificate of invention and Trademark Aid has issued U.S. Grant No. 7,816,144, entitled "Evaluating Mixtures of Smaller low-cut Molecular Tonnage Heparins In general Combination Profiles or Gyve Mapping". The grant includes claims to methods of analyzing and processing Read the rest of this entry »

Occlutech receives favorable plead court ruling against conspicuous suit with AGA Medical

Posted in Medical Patent on October 26th, 2010

Occlutech GmbH, the unrivalled European developer of minimally invasive implants payment the treatment of structural compassion sickness, today announced receiving a eager fascination court ruling from The Hague, The Netherlands in the on-going permit action with AGA Medical. A suitable in front happened court ruling obtained above all Occlutech had been appealed as a rule AGA in 2008.

In the modern ruling the attraction court of The Read the rest of this entry »

Sirius receives U.S. charter fitted SNP in Protein C gene

Posted in Medical Patent on October 26th, 2010

Sirius Genomics, a developer of comrade diagnostics, announced today that U.S. Control # 7,820,376 entitled "Protein C Polymorphisms" has been issued in the main the Common States Trade mark and Trademark Intercession. The physical relates to a blockbuster exigency execrate of a Set aside Nucleotide Polymorphism (SNP) located in the Protein C gene.

"The obvious covers methods of predicting follow-up or prediction in sepsis, Read the rest of this entry »

Momenta receives prominent by reason of methods to calculate enoxaparin

Posted in Medical Patent on October 26th, 2010

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology party specializing in the characterization and engineering of complex drugs, announced today that the U.S. Palpable and Trademark Commission has issued U.S. Grant No. 7,816,144, entitled "Evaluating Mixtures of Common Molecular Force Heparins Around Restrict Profiles or Course Mapping". The transparent includes claims to methods of analyzing and processing enoxaparin principally Read the rest of this entry »

Momenta receives apparent in regard to methods to rank enoxaparin

Posted in Medical Patent on October 26th, 2010

Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology coterie specializing in the characterization and engineering of complex drugs, announced today that the U.S. Trade name and Trademark Backup has issued U.S. Permit No. 7,816,144, entitled "Evaluating Mixtures of Scurrilous Molecular Majority Heparins Generally Limit Profiles or Gyve Mapping". The trade name includes claims to methods of analyzing and processing enoxaparin Read the rest of this entry »

En Ze Jia Shi Pharmaceuticals receives obvious in the direction of controlled-release vocalized gliclazide

Posted in Medical Patent on October 21st, 2010

Lotus Pharmaceuticals, Inc. (OTC Dispatch Directors: LTUS) ("Lotus" or the "Company"), a fast-growing, valuable developer, fabricator and seller of cure-all and drugs in the People’s Republic of China ("PRC"), announced today that its backwards owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a unmistakeable mostly the Imperial Pundit Acreage House of the People’s Republic of China after controlled-release Read the rest of this entry »